# Lymphoma trials recruiting, no drug phase: 163 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 163 trials with no drug phase for lymphoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting lymphoma trials with no drug phase: 163 rows for $8.15, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/lymphoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 163
- Recruiting or not yet: 163
- Read on: November 19, 2026

## Trials

The 25 newest of 163, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945470 | Simulation-Free Single-Fraction Radiation Therapy for Indolent Lymphoma | University Health Network, Toronto | Not applicable | Recruiting | Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Mantle... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945470) |
| November 3, 2026 | NCT07912684 | The Value of a Tailored-based, Exercise Program for Improving Quality of Life of Patients With Hematologic Malignancies: a Pilot Randomized... | Gruppo Italiano Malattie EMatologiche dell'Adulto | Not applicable | Recruiting | Acute Myeloid Leukemia, Multiple Myeloma, Lymphoma | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912684) |
| October 1, 2026 | NCT07852377 | Immunomonitoring and Predictive Biomarkers After CAR-T Cell Therapy in B-Cell Lymphoma and Multiple Myeloma | Centre Henri Becquerel | Not applicable | Not yet recruiting | B Cell Lymphoma, Multiple Mieloma | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852377) |
| September 18, 2026 | NCT07828730 | Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older | Sunnybrook Health Sciences Centre | Not applicable | Not yet recruiting | Moderate or Severe Aortic Stenosis | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828730) |
| September 14, 2026 | NCT07817641 | Proton Therapy for Mediastinal Lymphoma (PROMLY) | Copenhagen University Hospital, Rigshospitalet | Not applicable | Recruiting | Mediastinal Lymphoma, Hodgkin Disease Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL) | 139 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817641) |
| September 9, 2026 | NCT07810400 | A Study Of Remote Patient Monitoring (RPM) Program For Cancer Patients Initiating Cancer-directed Therapy | Mayo Clinic | Not applicable | Not yet recruiting | Cancer, Lymphoma | 470 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810400) |
| August 28, 2026 | NCT07793006 | New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease | Indiana University | Not applicable | Recruiting | HIV, Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease, Hodgkin Lymphoma, Non-Hodgkin Lymphoma... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793006) |
| August 24, 2026 | NCT07782944 | CD38 Targeted -PET/ CT for Multiple Myeloma | Guilin Medical University, China | Not applicable | Recruiting | Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782944) |
| August 14, 2026 | NCT07764601 | R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Primary Central Nervous System Lymphoma, Diffuse Large B-Cell Lymphoma | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764601) |
| August 7, 2026 | NCT07752056 | Low-Sodium Diet for Postpartum Blood Pressure Control | Women and Infants Hospital of Rhode Island | Not applicable | Not yet recruiting | Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Severe, Pre-Eclampsia; Mild, Postpartum | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752056) |
| August 7, 2026 | NCT07751783 | Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations | Kaohsiung Medical University Chung-Ho Memorial Hospital | Not applicable | Recruiting | Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Lung Cancer... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751783) |
| July 31, 2026 | NCT07739849 | Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in... | The Clatterbridge Cancer Centre NHS Foundation Trust | Not applicable | Not yet recruiting | Cancer, Lymphoma | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739849) |
| July 27, 2026 | NCT07727642 | Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma | Shanghai Public Health Clinical Center | Not applicable | Recruiting | AIDS-related Lymphoma, HIV Infection | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07727642) |
| July 17, 2026 | NCT07710781 | Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic... | Ossium Health, Inc. | Not applicable | Not yet recruiting | Hematologic Malignancy, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710781) |
| July 15, 2026 | NCT07705178 | More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL... | University of Erlangen-Nürnberg Medical School | Not applicable | Recruiting | Acute Lymphatic Leukemia, Lymphoma | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705178) |
| June 24, 2026 | NCT07664787 | Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study | Ruijin Hospital | Not applicable | Not yet recruiting | Hypertension, Grade 1 | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07664787) |
| June 8, 2026 | NCT07631598 | Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses | Montefiore Medical Center | Not applicable | Recruiting | Opioid Use Disorder, Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate | 512 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07631598) |
| June 2, 2026 | NCT07621887 | Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer | The Hong Kong Polytechnic University | Not applicable | Not yet recruiting | Hematologic Cancer, Leukaemia, Lymphoma, Physical Activity | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621887) |
| May 27, 2026 | NCT07609030 | A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or... | Ohio State University Comprehensive Cancer Center | Not applicable | Recruiting | Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Multiple Myeloma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609030) |
| May 27, 2026 | NCT07608549 | FLASH Pilot Phase 1 Safety Study | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Cutaneous Lymphoma | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07608549) |
| May 18, 2026 | NCT07592481 | Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors | Centre Hospitalier de la côte Basque | Not applicable | Not yet recruiting | Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma ( FL), Waldenstrom Macroglobulinaemia, Lymphoplasmacytic... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592481) |
| April 28, 2026 | NCT07553572 | Remote Monitoring and Symptom Management Digital Application | Sponsor not shown (see the record) | Not applicable | Recruiting | Breast Cancer (Locally Advanced or Metastatic), Lymphoma, Colorectal Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07553572) |
| April 21, 2026 | NCT07542912 | Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma | Sun Yat-sen University | Not applicable | Not yet recruiting | Complete Remission Rate， CRR, Progression Free Survival, Overall Survival, Adverse Event, Duration of Response | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07542912) |
| March 24, 2026 | NCT07490925 | Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS | Beijing Chao Yang Hospital | Not applicable | Recruiting | ARDS (Moderate or Severe) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07490925) |
| March 17, 2026 | NCT07476378 | A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not applicable | Not yet recruiting | Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Follicular, Lymphoma, Mantle-Cell, Chronic Lymphocytic Leukemia... | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476378) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Miami | 4 |
| University Health Network, Toronto | 4 |
| Hospices Civils de Lyon | 3 |
| Massachusetts General Hospital | 3 |
| University Hospital, Angers | 3 |
| Peking University People's Hospital | 3 |
| University of Nebraska | 3 |
| Dana-Farber Cancer Institute | 3 |
| The First Affiliated Hospital of Soochow University | 2 |
| Fondazione Italiana Linfomi - ETS | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Shanxi Bethune Hospital | 2 |
| Ruijin Hospital | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Mayo Clinic | 2 |
| Anhui Provincial Hospital | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| [Hebei Senlang Biotechnology Inc., Ltd.](https://specstream.ai/data/clinical-trials/company/hebei-senlang-biotechnology-inc-ltd) | 2 |
| Beijing GoBroad Hospital | 2 |
| Yale University | 2 |
| University of Washington | 2 |
| University of Texas at Austin | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| University of Wisconsin, Madison | 1 |
| Innoblative Designs, Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 51 |
| China | 37 |
| France | 19 |
| Italy | 8 |
| Canada | 6 |
| Germany | 5 |
| Spain | 5 |
| Denmark | 4 |
| Netherlands | 4 |
| Norway | 2 |
| Hong Kong | 2 |
| Sweden | 2 |
| India | 2 |
| Egypt | 2 |
| Zambia | 1 |
| Israel | 1 |
| Thailand | 1 |
| Indonesia | 1 |
| Brazil | 1 |
| South Korea | 1 |
| Poland | 1 |
| Portugal | 1 |
| Taiwan | 1 |
| Malawi | 1 |
| Slovenia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Occupational therapy clinics in the United States](https://specstream.ai/data/businesses/occupational-therapy-clinics/united-states)
- [Oncology practices in the United States](https://specstream.ai/data/businesses/oncology-practices/united-states)
- [Optometrists in the United States](https://specstream.ai/data/businesses/optometrists/united-states)
- [Orthopedic surgery practices in the United States](https://specstream.ai/data/businesses/orthopedic-surgery-practices/united-states)
- [Osteopathic practices in the United States](https://specstream.ai/data/businesses/osteopathic-practices/united-states)
- [Outpatient care facilities in the United States](https://specstream.ai/data/businesses/outpatient-care-facilities/united-states)
